Massimo Maria D'Amato

Title: Massimo Maria D'Amato: Innovator in Pharmaceutical Treatments

Introduction

Massimo Maria D'Amato is a notable inventor based in Monza, Italy. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of viral hepatitis and airway diseases. With a total of four patents to his name, D'Amato's work reflects a commitment to advancing medical science.

Latest Patents

D'Amato's latest patents include a silibinin component for the treatment of hepatitis. This invention focuses on the use of a silibinin component for the production of a medicament designed for parenteral administration to treat viral hepatitis, specifically hepatitis B or C. The medicament aims to reduce the virus load and is formulated without silidianin, silichristin, or isosilibinin. Another significant patent involves the combination of Andolast, a calcium-activated potassium channel opener, with glucocorticoids for treating patients with airway diseases. This patent also discloses pharmaceutical compositions that incorporate both Andolast and glucocorticoids.

Career Highlights

Throughout his career, D'Amato has worked with reputable companies in the pharmaceutical industry, including Rottapharm Spa and Madaus GmbH. His experience in these organizations has contributed to his expertise in developing innovative treatments.

Collaborations

D'Amato has collaborated with notable professionals in the field, including Lucio C Rovati and Francesco Makovec. These partnerships have likely enhanced his research and development efforts.

Conclusion

Massimo Maria D'Amato stands out as an influential inventor in the pharmaceutical sector, with a focus on innovative treatments for viral hepatitis and airway diseases. His contributions continue to impact the medical community positively.